This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Antibodies, Monoclonal
|
|
Academic Article
|
Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
|
|
Academic Article
|
New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.
|
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
|
Academic Article
|
Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
|
|
Academic Article
|
Advanced or metastatic pancreatic cancer: molecular targeted therapies.
|
|
Academic Article
|
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
|
|
Academic Article
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
|
|
Academic Article
|
New directions in the management of advanced pancreatic cancer: a review.
|
|
Academic Article
|
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
|
|
Academic Article
|
EGFR targeting of solid tumors.
|
|
Academic Article
|
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
|